Japan· JP-6241006F1121

オフロキサシン

A ofloxacin product containing オフロキサシン, registered in Japan by アルフレッサファーマ, on the national reimbursement list. The same ATC class is registered in 10 of our 19 countries.

On Japan’s NHI price listATC J01MA01

Checked against MHLW / PMDA (Japan) on September 25, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about オフロキサシンAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Ofloxacin is registered in 10 of 19 countries.

Countries holding a registration under ATC J01MA01 (ofloxacin), each read from that country’s own register.

This record: Japan, from MHLW / PMDA (Japan)
6 of them publish a price we can compare per daily dose

Search ofloxacin products by name

Ofloxacin · ATC J01MA01

10 / 19 countries

Belgiumprice
Czechiaprice
Finlandprice
Germany
Japan
Netherlands
Norwayprice
Polandprice
United Kingdom
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of ofloxacin costs, country by country.

Normalised to the WHO defined daily dose (0.4 g), so markets compare like for like.

1 market with a comparable price for this class
Public list prices, converted to USD at the rate date shown

Open the full comparison — free account Drug prices for market access

Ofloxacin · price per daily dose (0.4 g)

USD · FX 28 Sept 2026

FR France$1.62

Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

MHLW / PMDA (Japan)

Active substance: オフロキサシン
Manufacturer: アルフレッサファーマ
Country: Japan (JP)
ATC code: J01MA01
ATC class: Ofloxacin
Defined daily dose: 0.4 g, O
Reimbursed: Yes
Source register: MHLW / PMDA (Japan)
Last checked: September 25, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

596 interactions on record for ofloxacin.

Graded by severity as the source publishes them — 86 severe. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check ofloxacin against other medicines How interaction checks work

Ofloxacin · interactions on record

596 records

86 severe
216 moderate
51 minor
170 info

Most severe, free to view

PapaverineA03AD01severe
CisaprideA03FA02severe
DolasetronA04AA04severe
PrednisoloneA07EA01severe

73 more interactions with mechanism and management, from a commercially licensed source.

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Ofloxacin in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All ofloxacin products

Authorised across Europe · EMA

The same active substance is authorised in 26 EEA countries. Names it is sold under:

Austria · Floxal, Floxal Edo
Belgium · Trafloxal, Trafloxal Edo
Bulgaria · Медофлоксин, Офлоксацин Дра
Cyprus · Cilox, Medofloxine
Czechia · Floxal, Ofloxacin Unimed Pharma
Germany · Floxal, Floxal Edo
Estonia · Medofloxine, Ofloxin
Spain · Exocin, Oflovir
Finland · Exocin
France · Exocine, Monoflocet
United Kingdom (Northern Ireland) · Exocin, Ofloxacin Bristol Laboratories
Greece · Exocin, Oxatrex
Croatia · Uniflox
Hungary · Floxal, Grenis-Oflo
Ireland · Exocin
Italy · Dunaflot, Exocin
Lithuania · Ofloxin, Uniflox
Luxembourg · Ofloxa-Vision Kombi-Packung, Visioflox
Latvia · Ofloxin, Uniflox
Malta · Uniflox Unimed Pharma
Netherlands · Ofloxacine 200 Pch, Ofloxacine 400 Pch
Poland · Floxal, Oflodinex
Portugal · Audret, Bioquil
Romania · Floxal, Ofloxacină Laropharm
Sweden · Ofloxacin Mibe
Slovakia · Medofloxine, Ofloxin

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of MHLW / PMDA (Japan). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/02ab1b24-2262-4dfc-9204-be77523290b5
GET /v1/drugs/02ab1b24-2262-4dfc-9204-be77523290b5?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "spec": "１００ｍｇ１錠",
  "marks": null,
  "source": "mhlw",
  "remarks": null,
  "yj_code": "6241006F1121",
  "category": "内用薬",
  "price_yen": 82.8,
  "generic_name": "オフロキサシン",
  "product_name_jp": null,
  "therapeutic_class": "6241",
  "transitional_expiry": null
}

API reference MCP server Plans

See everything about ofloxacin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console